Sanofi-aventis presented its new research and development model project. The model, which aims to transform R&D and increase innovation, is the first pillar of the Group's new strategy which was presented in February 2009 by Christopher A. Viehbacher, chief executive officer of sanofi-aventis.
Piramal Healthcare Ltd is expanding its contract manufacturing services to early phase business, offering supplies of clinical trial quantities both in active pharmaceutical ingredient (API) and formulation segments.
Japan-based pharmaceutical company Astellas Pharma announced its plans to foray into the Indian market and establish its business in the country by developing sales and marketing infrastructure for its products base.
A couple of years ago, the CEO of a leading European multinational drugmaker had notoriously called Indian pharmaceutical companies 'thieves', for making copycat versions of innovator drugs.
British companies are looking to partner with Indian clinical research organisations (CROs) in a bid to tap the $1 billion (about Rs 4,800 crore) clinical research market in India. This is on the back of growth in Europe having stagnated.
Ministry of Indigenous Medicine and the Department of Ayurveda, Sri Lanka, is organizing the 'Ayurveda 2009'- the biggest international exhibition and symposium on indigenous healthcare in Sri Lanka at the Bandaranaike Memorial International Conference Hall (BMICH), Colombo from May 23 - 25 2009....
The USA-India Chamber of Commerce (USAIC), a bilateral body committed to promoting and facilitating trade and investment between the two countries, is organizing its annual Indo-US BioPharma and Healthcare Summit in Boston on May 14.
Making sure that patients keep taking their medicines in a sluggish economy, in which some may choose to forego some items to save money, will be one of the issues tackled in an upcoming annual drug and pharmaceutical conference.
In its endeavour to help pharma players from other parts of the world to explore Japanese drug market, the second largest in the world, United Business Media, a leading organiser of trade shows and professional shows in Europe, US and Asia, would host its flagship...
The BIO-Europe Spring partnering conference scheduled to take place from March 16 to 18, 2009 at the Milano Convention Centre (MIC), Milan, Italy will host international biotech and pharma leaders for three days of partnering.
The USA-India Chamber of Commerce is organising 'US-India Biopharma & Healthcare Summit 2009' on May 14, 2009 at President's Ballroom, Hyatt Regency, Cambridge, Massachusetts, USA.
Sanofi-aventis, the world's leading vaccine manufacturer, officially launched the construction of a new Sanofi Pasteur vaccine manufacturing centre in Neuville-sur-Saône, France.
The pharmaceutical and biotechnology industry is in the process of consolidating and down-sizing while trying to maintain R&D productivity. Small and medium-sized companies are trying to make the most of available opportunities in niche segments.
Last year, the Biotech industry as a whole achieved much better performance than the market. Both the NASDAQ Biotech Index and AMEX Biotech Index outperformed all three major market indices (Dow Jones Industrial Average, NASDAQ Composite and S&P 500) in a large margin. The...
Lupin Ltd, one of the top five domestic pharmaceutical companies, plans to revamp its drug research programme and foray into novel biotech and reverse engineering of biotech drugs (or biosimilars).
GlaxoSmithKline (GSK) received European Commission authorisation for Synflorix, a paediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle ear infections. In Europe, approximately one in three cases of serious pneumococcal disease in young children caused...
Genentech Inc.'s (DNA) ability to leverage a higher price tag from Roche Holding AG (RHHBY) in an otherwise downtrodden market demonstrates the attractiveness of biotech assets, especially for the right buyer.
1.Indian Institute of Toxicology - Indian Institute of Toxicology (IIT) is one of the pioneers, independent Contract Research Organization (CRO) engaged in toxicology and has been in the business for the past 25 Years. The institute is committed to excellence, which is borne out of a State-of-art infrastructure & technical skills in the field of Toxicology Studies.... [English]-[French]-[Spanish]
DEAL WATCH
Zila, Inc has entered into a definitive merger agreement with Tolmar Holding, Inc, a privately held, pharmaceutical research, development, manufacturing and commercial operations company.
Pharma major Lupin has acquired the global rights for an intra-nasal steroid (INS) product, AllerNaze. The Mumbai-based company has acquired the rights from Collegium Pharmaceuticals , a mid-size innovator company in the US, it announced in a release on Tuesday.
Biocon has entered into a definitive agreement with Mylan Inc, for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace.
Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, and Chugai Pharmaceutical Co., Ltd., a leading Japanese research-based pharmaceutical company, have signed a multi-year contract for the use of the Genedata Expressionist® system to streamline their internal R&D process....
Elder Pharmaceuticals has signed an agreement with US-based MD Anderson Cancer Center to conduct human experiments for its newly-discovered anti-cancer drug.
Indian Pharma Companies Eye High Potency API Market Pie The Indian Active Pharmaceutical Ingredient (API) Industry is fast developing though many challenges exist as it....[English]-[French]-[Spanish]
Indian Biogenerics Firms Poised to Storm Western Markets With blockbuster first-generation biotherapeutics developed in the West are losing patent protection, Indian biopharma...[English] [French] [Spanish]
CLINICAL TRIALS
India is fast turning into a global hub of cost-effective clinical research outsourcing (CRO), thanks to the adaptation of international regulatory standards. The revenue from this sector is expected to touch $1 billion by 2010. From $70 million pumped in by just a few pharmaceutical...
Institute of Clinical Research (India), ICRI in collaboration with Cranfield University, UK has called for applications for its two year full time course, MSc in Clinical Research. The course will start on August 3 at all its campuses in Bangalore, Mumbai, Delhi, Ahmedabad &...
The contract research organisations in the country have called for better regulatory environment including permission for phase-1 clinical trials to attract more foreign companies to the land as the country has huge potential to improve its share in the global market.
Medivation, Inc has received written permission from the US Food and Drug Administration (FDA) to begin a pivotal phase-3 trial of MDV3100, its novel androgen receptor antagonist, in patients with metastatic castration-resistant prostate cancer (CRPC) who have failed docetaxel-based chemotherapy.
The Russian pharmaceutical market is forecasted to grow at a CAGR of 14% by 2012 in the backdrop of rising population of elders and government’s initiatives to reform healthcare system.
Is rural India a new promised land for drugmakers? Several multinational pharma companies are targeting the subcontinent's countryside for expansion, local media reports. It's part of pharma's new focus on emerging markets but with a twist.
The recent warning letters issued by the US Food and Drug Administration (FDA), to manufacturing units of Indian pharmaceutical companies, have significantly raised investors risk.
Sun Pharmaceutical has received a tentative approval to market Alfuzosin Hydrochloride Tablet in the strength of 10 mg from the United States Food and Drug Administration (USFDA).
The US Food and Drug Administration approved Simponi (golimumab), a monthly treatment for adults with moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis.
Sun Pharmaceutical Industries US arm has obtained a final approval from US Food and Drug Administration (US-FDA) to market Bethanechol Chloride drug on prescription basis.
Indian Pharma Companies Eye High Potency API Market Pie
Indian Biogenerics Firms Poised to Storm Western Markets
